| A First in Human Study of ORT247 in Healthy Volunteers (NCT06769620) | Orthogonal Neuroscience Inc. | 2022-06-06 |
| Quest to Analyze One Thousand Humans Meditating (NCT06583395) | Tobias Moeller-Bertram | 2021-12-05 |
| Remotely Supervised tDCS for Slowing ALS Disease Progression (NCT04866771) | University of Illinois at Chicago | 2021-08-27 |
| Amyotrophic Lateral Sclerosis: A Multicenter Retrospective Observational Registry (NCT07143656) | Biocells Medical | 2021-05-13 |
| Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS) (NCT04577404) | Shionogi | 2020-10-29 |
| UPenn Observational Research Repository on Neurodegenerative Disease (NCT04715399) | University of Pennsylvania | 2020-05-29 |
| Biomarkers in Neurodegenerative Diseases (NCT04055532) | University of Minnesota | 2019-10-01 |
| A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease (NCT04031469) | ProgenaBiome | 2019-07-11 |
| Safety and Efficacy of TUDCA as add-on Treatment in Patients Affected by ALS (NCT03800524) | Humanitas Mirasole SpA | 2019-02-22 |
| A Follow up Study to Protocol 101/2 - Continued Treatment by IPL344 IV (NCT03755167) | Immunity Pharma Ltd. | 2018-12-09 |
| Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT03580616) | Elijah W. Stommel | 2018-10-24 |
| Acute Intermittent Hypoxia and Breathing in Neuromuscular Disease (NCT03645031) | University of Florida | 2018-10-01 |
| Circulating Biomarker for Amyotrophic Lateral Sclerosis (ALS) (NCT03088839) | Neuromed IRCCS | 2017-12-01 |
| Safety and Efficacy of Repeated Administrations of NurOwn® in ALS Patients (NCT03280056) | Brainstorm-Cell Therapeutics | 2017-08-28 |
| Retinal Imaging in Neurodegenerative Disease (NCT03233646) | Duke University | 2017-07-20 |
| Tracking and Predicting How Brain Damage Spreads in Neurodegenerative Diseases (NCT07567664) | IRCCS San Raffaele | 2017-06-01 |
| A Study for Patients Who Completed VITALITY-ALS (CY 4031) (NCT02936635) | Cytokinetics | 2016-10-17 |
| Imaging and BioFluid Biomarkers in Amyotrophic Lateral Sclerosis (NCT02559869) | Massachusetts General Hospital | 2015-11-01 |
| Brain and Nerve Stimulation for Hand Muscles in Spinal Cord Injury and ALS (NCT02469675) | Bronx VA Medical Center | 2015-06-01 |
| Neuroinflammation in Amyotrophic Lateral Sclerosis - Mechanisms and Therapeutic Perspectives: a Translational Pilot Study Among ALS Patients (NCT02424669) | Assistance Publique Hopitaux De Marseille | 2015-05-01 |
| A Registry-Based Clinical Trial of Pimozide in Patients With Neuromuscular Junction Transmission Dysfunction Due to ALS (NCT02463825) | University of Calgary | 2015-04-01 |
| F 18 T807 Tau PET Imaging in Familial Amyotrophic Lateral Sclerosis (NCT02414230) | Tammie L. S. Benzinger, MD, PhD | 2015-02-01 |
| "New Perspectives of Adaptation to NIV in ALS" (NCT02537132) | Fondazione Don Carlo Gnocchi ETS | 2015-01-01 |
| A Study to Evaluate the Performance of a Diagnostic Test in ALS (NCT02759913) | Iron Horse Diagnostics, Inc. | 2015-01-01 |
| Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) (NCT02365922) | University of California, San Francisco | 2014-09-01 |
| Oral Nutritional Supplementation in Amyotrophic Lateral Sclerosis (ALS) Patients (NCT02152449) | University Hospital, Limoges | 2014-07-01 |
| Non-invasive Ventilation in Amyotrophic Lateral Sclerosis (ALS) Using the iVAPS Mode (NCT01746381) | Marta Kaminska | 2014-02-01 |
| Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS) (NCT01786603) | Richard Barohn, MD | 2013-11-21 |
| Immunosuppression in Amyotrophic Lateral Sclerosis (ALS) (NCT01884571) | Emory University | 2013-10-01 |
| Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders (NCT02118805) | Beth Israel Deaconess Medical Center | 2013-10-01 |
| PET Imaging in ALS Patients (NCT02236897) | Johns Hopkins University | 2013-08-01 |
| Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS) (NCT01938495) | Barrow Neurological Institute | 2013-08-01 |
| Magnetic Resonance Imaging (MRI) in Amyotrophic Lateral Sclerosis (ALS) (NCT01945853) | Johns Hopkins University | 2013-07-01 |
| Clinical Trial Nuedexta in Subjects With ALS (NCT01806857) | Center for Neurologic Study, La Jolla, California, | 2013-04-01 |
| Masitinib in Combination With Riluzole for the Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS) (NCT02588677) | AB Science | 2013-04-01 |
| Determining the Safety of L-serine in ALS (NCT01835782) | Phoenix Neurological Associates, LTD | 2013-01-01 |
| Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance Myography (NCT01803386) | Skulpt, Inc. | 2013-01-01 |
| Safety and Efficacy on Spasticity Symptoms of a Cannabis Sativa Extract in Motor Neuron Disease (NCT01776970) | Ospedale San Raffaele | 2013-01-01 |
| DNA, Blood and Skin Cell Repository for Research on ALS and Related Neurodegenerative Disorders at Mayo Clinic Florida (NCT01699451) | Mayo Clinic | 2012-09-01 |
| Humanitarian Device Exemption Post-Approval Study of NeuRx Diaphragm Pacing System for Amyotrophic Lateral Sclerosis (NCT01605006) | Synapse Biomedical | 2012-07-01 |
| Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (NCT01492686) | Shionogi | 2011-12-31 |
| Trial of Safety and Efficacy of Rasagiline in Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT01232738) | Yunxia Wang, MD | 2011-12-01 |
| A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery (NCT01592552) | Sanguine Biosciences | 2011-11-01 |
| PRISM Registry: Pseudobulbar Affect Registry Series (NCT01366027) | Avanir Pharmaceuticals | 2011-05-01 |
| Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS) (NCT00876772) | Charite University, Berlin, Germany | 2011-03-01 |
| Safety and Tolerability of Anakinra in Combination With Riluzol in Amyotrophic Lateral Sclerosis (NCT01277315) | Charite University, Berlin, Germany | 2011-02-01 |
| A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS) (NCT00694941) | Ono Pharmaceutical Co., Ltd. | 2008-06-01 |
| A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT00445172) | Eisai Co., Ltd. | 2008-02-01 |
| Polysomnography-directed Noninvasive Ventilation in Amyotrophic Lateral Sclerosis (ALS) (NCT01363882) | Columbia University | 2008-02-01 |
| A Study in Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT00444613) | Eisai Co., Ltd. | 2007-04-01 |
| Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT00424463) | Shionogi | 2007-01-31 |
| Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Who Met Severity Classification III (NCT00415519) | Shionogi | 2006-12-31 |
| Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT00403104) | Ono Pharmaceutical Co., Ltd. | 2006-11-01 |
| Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) (NCT00330681) | Shionogi | 2006-05-31 |
| Pilot-Study of Thalidomide in Amyotrophic Lateral Sclerosis (ALS) (NCT00231140) | Charite University, Berlin, Germany | 2005-12-01 |
| A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS (NCT00244244) | CytRx | 2005-10-01 |
| Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT00420719) | Synapse Biomedical | 2004-10-01 |
| Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis (NCT00069186) | The Avicena Group | 2003-06-01 |
| Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS] (NCT00214110) | University of Wisconsin, Madison | 2001-01-01 |
| Genetics of Familial and Sporadic ALS (NCT00821132) | Northwestern University | 1991-01-01 |